Contineum Therapeutics In... (CTNM)
NASDAQ: CTNM
· Real-Time Price · USD
11.35
0.60 (5.58%)
At close: Oct 03, 2025, 3:59 PM
11.13
-1.94%
After-hours: Oct 03, 2025, 04:22 PM EDT
5.58% (1D)
| Bid | 10.87 |
| Market Cap | 318.27M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -56.86M |
| EPS (ttm) | -2.07 |
| PE Ratio (ttm) | -5.48 |
| Forward PE | -3.95 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 11.5 |
| Volume | 84,301 |
| Avg. Volume (20D) | 258,084 |
| Open | 11.06 |
| Previous Close | 10.75 |
| Day's Range | 10.80 - 11.57 |
| 52-Week Range | 3.35 - 20.24 |
| Beta | 1.29 |
| Ex-Dividend Date | n/a |
About CTNM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTNM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTNM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsContineum Therapeutics Inc. Class A Common Stock is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+9.76%
Contineum Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
